United States · FDA National Drug Code directory

amoxicillin and clavulanate potassium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62135-095_57477f96-ff03-67dc-e063-6294a90ad89d
Product NDC: 62135-095
Form: POWDER, FOR SUSPENSION
Composition / generic term: amoxicillin and clavulanate potassium
Labeler: Chartwell RX, LLC
Marketing category: ANDA
Marketing start / end (source format): 20040923
Source listing expiry: 20271231

Source-listed ingredients

AMOXICILLIN — 600 mg/5mL
CLAVULANATE POTASSIUM — 42.9 mg/5mL

These values do not establish equivalence or a dose recommendation.

Packages

125 mL in 1 BOTTLE (62135-095-13) · 62135-095-13
200 mL in 1 BOTTLE (62135-095-22) · 62135-095-22
75 mL in 1 BOTTLE (62135-095-75) · 62135-095-75

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →